Endothelial cells are important in the pathogenesis of bloodstream infections caused by Candida albicans and Staphylococcus aureus. Numerous investigations have used human umbilical vein endothelial cells (HUVECs) to study microbial-endothelial cell interactions in vitro. However, the use of HUVECs requires a constant supply of umbilical cords, and there are significant donor-to-donor variations in these endothelial cells. The use of an immortalized endothelial cell line would obviate such difficulties. One candidate in this regard is HMEC-1, an immortalized human dermal microvascular endothelial cell line. To determine if HMEC-1 cells are suitable for studying the interactions of C. albicans and S. aureus with endothelial cells in vitro, we compared the interactions of these organisms with HMEC-1 cells and HUVECs. We found that wild-type C. albicans had significantly reduced adherence to and invasion of HMEC-1 cells as compared to HUVECs. Although wild-type S. aureus adhered to and invaded HMEC-1 cells similarly to HUVECs, an agr mutant strain had significantly reduced invasion of HMEC-1 cells, but not HUVECs. Furthermore, HMEC-1 cells were less susceptible to damage induced by C. albicans, but more susceptible to damage caused by S. aureus. In addition, HMEC-1 cells secreted very little IL-8 in response to infection with either organism, whereas infection of HUVECs induced substantial IL-8 secretion. This weak IL-8 response was likely due to the anatomic site from which HMEC-1 cells were obtained because infection of primary human dermal microvascular endothelial cells with C. albicans and S. aureus also induced little increase in IL-8 production above basal levels. Thus, C. albicans and S. aureus interact with HMEC-1 cells in a substantially different manner than with HUVECs, and data obtained with one type of endothelial cell cannot necessarily be extrapolated to other types.
Citation: Seidl K, Solis NV, Bayer AS, Hady WA, Ellison S, Klashman MC, et al. (2012) Divergent Responses of Different Endothelial Cell Types to Infection with Candida albicans and Staphylococcus aureus. PLoS ONE 7(6): e39633. https://doi.org/10.1371/journal.pone.0039633
Editor: Carol A. Munro, University of Aberdeen, United Kingdom
Received: January 27, 2012; Accepted: May 27, 2012; Published: June 22, 2012
Copyright: © 2012 Seidl et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported by grants of the Foundation for Research at the Medical Faculty, University of Zurich, Switzerland and Matching Funds of the Clinical Trials Center, University Hospital Zurich, Switzerland to K.S., the American Heart Association grants SDG 0630219N and GIA 09GRNT2180065 to Y.Q.X., and the U.S. National Institutes of Health grants (R01AI39108 to A.S.B., and R01AI054928 to S.G.F.). The endothelial cells used in these studies were isolated from human umbilical cords, which were collected by the pediatric, perinatal and mobile unit of the UCLA Clinical and Translational Science Institute at LA BioMed/Harbor-UCLA Medical Center (UL1TR000124). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing interests: SGF is one of the founders of NovaDigm Therapeutics and serves on its scientific advisory board. This does not alter the authors’ adherence to all the PLoS ONE policies on sharing data and materials.
Endothelial cells play a crucial role in the pathogenesis of many types of human infections , . For example, after a microbial pathogen enters the circulation, it must adhere to and invade the endothelial cell lining of the blood vessels to infect deeper tissues to cause organ dissemination. In addition, by expressing pro-inflammatory cytokines and leukocyte adhesion molecules, endothelial cells recruit phagocytes to foci of infection and are therefore essential for orchestrating the host defense against microbial pathogens.
Because of the importance of endothelial cells in the pathogenesis of bloodstream infections, numerous investigators have used in vitro models of microbial-endothelial cell interactions to study the mechanisms by which distinct microbial pathogens adhere to, invade, damage, and activate endothelial cells. Many of these investigations have used human umbilical vein endothelial cells (HUVECs) –. For example, mutants of Candida albicans with reduced capacity to damage HUVECs in vitro are likely to have attenuated virulence in a murine model of hematogenously disseminated candidiasis . Also, the capacity of clinical isolates of Staphylococcus aureus to damage HUVECs is directly correlated with their virulence in the rabbit model of infective endocarditis, and inversely correlated with their response to vancomycin in this animal model . Thus, these investigations demonstrate that HUVECs may serve as a useful in vitro model of host-pathogen interaction.
There are some disadvantages to using HUVECs for such studies. Firstly, because they are primary cells, they exhibit significant donor-to-donor variability in some microbial interactions . Secondly, they have a relatively short life span in vitro, and their phenotype can change with successive passages. Thirdly, HUVECs can be difficult to transfect, and their finite life span makes it problematic to develop stably transfected cell lines. Finally, the availability of HUVECs may be constrained by medical and ethical issues.
To overcome these problems, immortalized endothelial cell lines have been developed. These cell lines have the advantages of easier maintenance, longer life span, less variability, and better availability. However, immortalization may lead to functional defects, such as altered expression of leukocyte adhesion molecules , . In addition, endothelial cells from different vascular beds have a diversity of phenotypes in terms of their cell morphology, function, gene expression, and antigen composition (Reviewed in , ). Thus, endothelial cells from different anatomic sites may exhibit marked differences in their interactions with microbial pathogens.
One immortalized cell line that has been used in studies of microbial pathogenicity is the HMEC-1 cell line. This cell line was developed by transfecting dermal human microvascular endothelial cells from human foreskin with a plasmid containing the simian virus 40A gene . These cells have been used to study the endothelial cell interactions of multiple microorganisms, including Chlamydia pneumoniae , Brucella spp. , Bartonella henselae , Mycobacterium tuberculosis , Orientia (Rickettsia) tsutsugamushi , Rickettsia rickettsii , Candida albicans , , and Staphylococcus aureus .
In order to evaluate the usefulness of HMEC-1 cells for studying different aspects of endovascular infection, we compared the interactions of C. albicans and S. aureus with these cells and HUVECs. We discovered that C. albicans and S. aureus interacted with HMEC-1 cells in a significantly different manner as compared to HUVECs.
C. albicans, but Not S. aureus, has Reduced Adherence to and Invasion of HMEC-1 Cells
We first compared the capacity of C. albicans and S. aureus to adhere to and invade HMEC-1 cells and HUVECs. Because C. albicans invades and damages endothelial cells much more rapidly than does S. aureus , , , , , , , , the C. albicans-endothelial cell interactions were assessed at earlier time points than the S. aureus-endothelial cell interactions. We found that wild-type C. albicans cells had 23% lower adherence and 47% less invasion of HMEC-1 cells compared to HUVECs (p<0.05 and p<0.001 for adherence and invasion, respectively) (Fig. 1A). In contrast, a wild-type strain of S. aureus adhered to and invaded HMEC-1 cells similarly to HUVECs (Fig. 1B).
Adherence and endocytosis of C. albicans strain CAI4+CIp10 was assessed 1.5 h after infection at a MOI of 1 (A). Adherence and endocytosis of S. aureus strain 6850 was determined 3 h after infection at a MOI of 1 (B). *, p<0.05 and ***, p<0.001 in HMEC-1 vs. HUVECs.
Next, we investigated whether microbial adherence to and invasion of HMEC-1 cells and HUVECs occur via the same mechanism(s). C. albicans Ssa1 and Als3 are invasin proteins that are necessary for maximal endothelial cell adherence and invasion (Table 1, , ). We found that ssa1Δ/Δ and als3Δ/Δ mutant strains were defective in their capacity to adhere to and invade both HMEC-1 cells and HUVECs (Table 2). The magnitude of these defects was similar for both HUVECs and HMEC-1 cells, indicating that Ssa1 and Als3 mediate adherence to and invasion of both types of endothelial cells.
We also evaluated the adherence and invasion of two S. aureus mutants. One strain was JB-1, a stable gentamicin-induced small-colony variant (SCV) of the clinical parental strain, 6850 (Table 1). SCV strains are known to persist within endothelial cells, while causing little damage , , . The second strain was an agr deletion mutant of clinical MRSA isolate 300-169 (Table 1, , ). agr, the accessory gene regulatory locus of S. aureus governs the expression of many adhesins and secreted virulence factors, such as proteases and toxins, and is known to affect host cell binding and invasion , , . We found that while the SCV mutant adhered to HMEC-1 cells similarly to its wild-type parent strain, it had slightly decreased adherence to HUVECs (Table 2). Also the SCV strain had increased capacity to invade both types of endothelial cells as compared to parental strain, 6850 (Table 2). Although the adherence of the agr mutant to HMEC-1 cells and HUVECs was similar to that of its wild-type parental strain, this mutant was defective in invading HMEC-1 cells, but not HUVECs (Table 2). There was a non-significant trend (p = 0.06) towards reduced invasion of HMEC-1 cells compared to HUVECs by the agr mutant, suggesting that agr may be required for S. aureus to maximally invade HMEC-1 cells, but not HUVECs.
HMEC-1 Cells and HUVECs Differ in their Susceptibility to Damage Caused by C. albicans and S. aureus
The susceptibility of HMEC-1 cells and HUVECs to damage induced by C. albicans was determined by a 51Cr release assay. We found that HMEC-1 cells were significantly less susceptible than HUVECs to damage caused by the wild-type strain. For example, at the lowest multiplicity of infection (MOI), C. albicans induced 50% less damage to HMEC-1 cells as compared to HUVECs (Fig. 2A). Furthermore, both the ssa1Δ/Δ and als3Δ/Δ mutants caused significantly less damage to HMEC-1 cells than to HUVECs (Table 3). This reduction in damage was due to deletion of ALS3 and SSA1 because integrating an intact copy of these genes into the respective deletion mutants restored their capacity to damage both types of endothelial cells. Interestingly, both the als3Δ/Δ and ssa1Δ/Δ mutants had significantly greater damage defects on HMEC-1 cells than on HUVECs. Collectively, these results indicate that HMEC-1 cells are more resistant to C. albicans-induced damage than HUVECs. In addition, the presence of Ssa1 and Als3 on the surface of C. albicans is more important for damage of HMEC-1 cells than HUVECs.
The extent of damage to the indicated endothelial cells was determined by a 51Cr release assay, and was measured after 6 h of infection with C. albicans CAI4+CIp10 (A) and after 24 h of infection with S. aureus 6850 (B). **, p<0.01 and ***, p<0.001 in HMEC-1 vs. HUVECs.
In contrast to C. albicans, wild-type S. aureus caused significantly more damage to HMEC-1 cells than to HUVECs (Fig. 2B). As expected , the SCV and agr mutant strains had reduced capacity to damage both endothelial cell types (Table 3). However, the SCV strain caused significantly greater damage to HMEC-1 cells than to HUVECs, whereas the agr mutant caused greater damage to HUVECs than to HMEC-1 cells. Therefore, the mechanisms by which S. aureus damages HMEC-1 cells and HUVECs are likely to be different.
HMEC-1 Cells Secreted Little IL-8 in Response to C. albicans and S. aureus Infection
The proinflammatory chemokine, IL-8, plays a key role in activating and recruiting neutrophils and monocytes to sites of infection . We therefore compared the secretion of IL-8 by HMEC-1 cells vs. HUVECs in response to microbial infection. After 6 h, uninfected HMEC-1 cells secreted approximately 10-fold less IL-8 than did HUVECs (Fig. 3A). Furthermore, when HMEC-1 cells were infected with wild-type C. albicans, secretion of IL-8 increased by a maximum of only 1.8-fold (p = 0.138). In contrast, infection of HUVECs with wild-type C. albicans resulted in up to a 5-fold increase in IL-8 secretion, depending on the MOI (p<0.05 for all MOIs tested). Thus, IL-8 secretion by HMEC-1 cells is poorly responsive to C. albicans infection.
IL-8 levels in conditioned media of HUVECs, HMEC-1 cells, and HDMECs were determined 6 h after infection with C. albicans DAY185 (A) and 24 h after infection with S. aureus 6850 (B). Ctrl, uninfected controls; *, p<0.05; **, p<0.01; and ***, p<0.001 in HMEC-1 or HDMEC vs. HUVECs; †, p<0.05; and †††, p<0.001 in conditioned media vs. uninfected controls.
HMEC-1 cells also responded weakly to S. aureus. During the 24 h incubation period, the basal release of IL-8 in the absence of infection was similar for HMEC-1 cells and HUVECs (Fig. 3B). Infection of HMEC-1 cells with S. aureus stimulated only a slight increase in IL-8 secretion at all MOIs tested. For instance, maximal increase in IL-8 secretion occurred at an MOI of 5, which resulted in only a 1.5-fold induction compared to uninfected control HMEC-1. In contrast, IL-8 production by HUVECs was highly inoculum-dependent. While the lowest inoculum tested (MOI of 0.5) did not induce a significant increase in IL-8 secretion, infection at MOIs of 5 and 50 led to a 4-fold and 2.3-fold increase in IL-8 secretion, respectively. At the highest MOI tested (500) there was no detectable increase in IL-8 secretion, probably because most endothelial cells were killed by this high inoculum. Collectively, these results indicate that HMEC-1 cells produce very little IL-8 in response to infection with either C. albicans or S. aureus, whereas IL-8 secretion by HUVECs is strongly induced by both organisms.
To investigate whether the low IL-8 production by the HMEC-1 cells was due to the anatomic source of these endothelial cells or their viral transformation, we analyzed the IL-8 response of primary human dermal microvascular endothelial cells (HDMECs). The basal release of IL-8 by these endothelial cells was significantly greater than that of both HUVECs and HMEC-1 cells after 6 h (Fig. 3). However, infection with three different inocula of C. albicans did not induce a significant increase in IL-8 production by HDMECs (Fig. 3A), and S. aureus induced only a 1.6-fold increase in IL-8 production at an MOI of 0.5 (Fig. 3B). Therefore, although the low basal production of IL-8 by HMEC-1 cells is likely the result of their transformation, the minimal increase in IL-8 production in response to C. albicans and S. aureus infection is probably due to the anatomic source of these endothelial cells.
Although both HUVECs and HMEC-1 cells have been used to investigate the interactions of microbial pathogens with endothelial cells in vitro, there have been relatively few studies that directly compared the response of these two types of endothelial cells to infection by prototypical endovascular pathogens. We determined that C. albicans and S. aureus interacted significantly differently with HMEC-1 cells as compared to HUVECs. For example, wild-type C. albicans was less adherent to HMEC-1 cells than to HUVECs. Furthermore, although we found that the als3Δ/Δ and ssa1Δ/Δ mutants had reduced adherence to both types of endothelial cells when tested under static conditions, it remains possible that C. albicans adheres by different mechanisms to HMEC-1 cells than to HUVECs under flow conditions. For instance, one group reported that C. albicans hyphae are less adherent than yeast to HMEC-1 cells under flow conditions , whereas another group found that C. albicans hyphae have greater adherence to HUVECs than do yeast-phase organisms under conditions of flow . Collectively, these results suggest that the endothelial cells receptors that are bound by C. albicans may differ in either their expression level or composition between HMEC-1 cells and HUVECs.
We also found that C. albicans hyphae were endocytosed less avidly by HMEC-1 cells than by HUVECs. It is known that C. albicans hyphae induce their own endocytosis by binding to N-cadherin on the surface of endothelial cells . Although both HUVECs and HMEC-1 cells express N-cadherin , it is possible that the binding of C. albicans to N-cadherin may activate divergent signaling pathways in these two types of cells. Alternatively, receptors other than N-cadherin, which also mediate the endocytosis of C. albicans might be expressed at higher level by HUVECs than by HMEC-1 cells.
In addition, we determined that wild-type S. aureus cells were endocytosed similarly by HUVECs and HMEC-1 cells, whereas an SCV strain had markedly enhanced invasion of both endothelial cell types as compared to its parental isolate. SCV strains have previously been reported to have increased invasion of HUVECs ,  and bovine aortic endothelial cells , probably due to enhanced expression of fibronectin-binding proteins, which are the essential mediators of S. aureus invasion of host cells –.
Interestingly, although an agr mutant had normal adherence to both endothelial cell types as compared to its parental strain, it was defective in invading HMEC-1 cells, but not HUVECs. The role of agr in governing S. aureus adherence to endothelial cells is known to be influenced by multiple factors, including the strain background, growth phase, and whether adherence is measured under static or flow conditions , . Thus, even though agr did not affect endothelial cell adherence in our investigations, it might have done so under different experimental conditions. In concordance with our data, others have found that agr is dispensable for S. aureus invasion of HUVECs . However, our finding that agr is necessary for maximal invasion of HMEC-1 cells again demonstrates that S. aureus interacts differently with this endothelial cell line as compared to HUVECs.
As expected, C. albicans caused significant damage to HMEC-1 cells and HUVECs. However, we found that wild-type C. albicans caused significantly less damage to HMEC-1 cells than to HUVECs. Furthermore, damage to HMEC-1 cells was more dependent on the presence of the C. albicans Ssa1 and Als3 invasins than was damage to HUVECs. It is known that C. albicans must invade endothelial cells to cause maximal damage to these cells . However the ssa1Δ/Δ and als3Δ/Δ mutant strains had similar defects in their capacity to invade both HMEC-1 cells and HUVECs. Thus, the differential susceptibility of HMEC-1 cells vs. HUVECs to damage caused C. albicans might be due to differences in post-invasion processes such as intracellular trafficking or activation of signal transduction pathways.
In sharp contrast to C. albicans, S. aureus caused significantly more damage to HMEC-1 cells as compared to HUVECs. Because wild-type S. aureus cells were endocytosed similarly by both types of endothelial cells, the differential susceptibility of HMEC-1 cells and HUVECs to S. aureus-induced damage must also be due to post- endothelial cell invasion events. Importantly, the hyper-adherent SCV strain had the greatest damage defect on HUVECs, whereas the agr mutant had the greatest damage defect on HMEC-1 cells. Thus, the changes in S. aureus that occur during SCV formation influence its ability to damage HUVECs more than HMEC-1 cells. Conversely, factors controlled by agr (e.g., cytolytic toxins) mediate S. aureus-induced damage of HMEC-1 cells more than HUVECs.
We found that both C. albicans and S. aureus induced HUVECs to secrete IL-8, as has been reported previously , –. However, under the conditions tested, C. albicans did not stimulate significant IL-8 production by HMEC-1 cells, while S. aureus induced only a minor increase in IL-8 production by these endothelial cells. Of note, HMEC-1 cells have been shown to produce much lower levels of IL-8 than do HUVECs in response to other stimuli, such as IL-1β and Brucella abortus , . Importantly, the production of additional proinflammatory and proangiogenic factors such as IL-6, vascular cell adhesion molecule-1, E-selectin, and vascular endothelial cell growth factor is much lower in HMEC-1 cells as compared to HUVECs , . Our data with primary HDMECs suggest that while the low basal production of IL-8 by the HMEC-1 cells may be due to their transformation, the poor IL-8 production by these endothelial cells in response to C. albicans and S. aureus may be a general property of dermal microvascular endothelial cells. Nevertheless, these collective findings suggest that HUVECs are preferable to HMEC-1 cells for studying the effects of C. albicans and S. aureus on stimulation of the endothelial cell proinflammatory response.
In summary, our current data indicate that C. albicans and S. aureus interact with HMEC-1 cells significantly differently than with HUVECs. Thus, data obtained with one type of endothelial cell cannot necessarily be extrapolated to other types obtained from different vascular beds. Furthermore, both primary and transformed dermal microvascular endothelial cells release very little IL-8 above basal levels in response to C. albicans or S. aureus infection, in contrast to HUVECs. On the other hand, HMEC-1 cells may be particularly useful for investigating mechanisms of endothelial cell damage that depend upon the C. albicans Ssa1 and Als3 invasins or the target genes of the S. aureus agr regulon. Moreover, a key consideration when deciding which type of endothelial cell to use to investigate microbial-endothelial cell interactions in vitro is how well these interactions are predictive of the events that occur during in vivo infection. We have found previously that the capacity of different strains of C. albicans and S. aureus to damage HUVECs in vitro is directly correlated with their virulence in animal models of hematogenous infection , . Whether one or more interactions of these microbial pathogens with HMEC-1 cells is also predictive of virulence will be the focus of future investigations.
Materials and Methods
The protocol for collecting umbilical cords for the harvesting of HUVECs used in these studies was approved by the Institutional Review Board of the Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center. This protocol was granted a waiver of consent because the donors remained anonymous.
Endothelial Cell Culture
HUVECs were harvested from human umbilical cord veins by the method of Jaffe et al. , and maintained in complete M199 medium (with 10% fetal bovine serum and 10% bovine calf serum, plus penicillin, 100 IU/ml; streptomycin, 100 µg/ml) as previously described . HUVECs were routinely used at passage 3 for various assays. HMEC-1 cells were obtained from Kathryn Kellar of the Centers for Disease Control (CDC), and maintained as recommended . HDMECs were purchased from Lonza BioResearch and grown as directed. All experiments in which HUVECs were compared with HMEC-1 cells were performed in parallel.
Bacterial and Fungal Strains and Growth Conditions
We selected C. albicans and S. aureus for these investigations as they represent two prototypical endovascular pathogens. All C. albicans and S. aureus strains used in this study are listed in Table 1. For use in the experiments, C. albicans yeast-phase cells were grown in YPD (1% yeast extract, 2% Bacto-peptone, 2% D-glucose) broth overnight in a rotary shaker at 30°C. All S. aureus strains were grown overnight in Bacto BHI broth (Difco) without shaking at 37°C. On the day of the experiment, the organisms were harvested by centrifugation and washed with PBS. The C. albicans cells were counted using a hemacytometer and the S. aureus cells were adjusted to an OD600 of 0.5 and diluted accordingly. S. aureus inocula were confirmed by quantitative culture. The construction of the C. albicans ssa1Δ/Δ+SSA1 and als3Δ/Δ+ALS3 complemented strains was described previously , . Attempts to genotypically and phenotypically complement the entire agr operon in the 300-169Δagr mutant were unsuccessful, as has been reported by others .
Adherence and Endocytosis Assays
The capacity of the various C. albicans strains to adhere to and be endocytosed by HUVECs and HMEC-1 cells was quantified using our previously described differential fluorescence assay . Briefly, the endothelial cells were grown on 12-mm-diameter glass cover slips and inoculated at a MOI of 1 in RPMI 1640 medium. After 1.5 h, the nonadherent organisms were removed by rinsing with Hanks balanced solution (HBSS), after which the cells were fixed with 3% paraformaldehyde. The adherent, extracellular organisms were stained with anti-C. albicans rabbit antiserum (Biodesign International) conjugated with Alexa Fluor 568 (red fluorescence; Molecular Probes). Next, the host cells were permeabilized in 0.5% Triton X-100, after which the cell-associated organisms (the adherent plus endocytosed organisms) were stained with anti-C. albicans antiserum conjugated with Alexa Fluor 488 (green fluorescence). For ease of discussion, organisms that were host-cell associated are referred to as “adherent”. The cover slips were mounted inverted on a microscope slide, and the number of endocytosed and cell-associated organisms was determined by viewing the cells with an epifluorescent microscope. At least 100 organisms were counted on each cover slip, and organisms that were partially internalized were scored as being endocytosed. Each experiment was carried out in triplicate on at least three separate occasions.
The capacity of the various S. aureus strains to adhere to and be endocytosed by endothelial cells was quantified using the lysostaphin protection assay , . Briefly, endothelial cells were grown to confluency and inoculated at a MOI of 1 in M199 invasion medium (M199 without antibiotics and serum, but with 1% human albumin, , ). After 3 h, one half of wells were washed three times with HBSS, after which the endothelial cells were detached and then lysed. The number of host-cell associated S. aureus was determined by quantitative culture. To determine the number of internalized bacteria, complete M199 medium with 10 µg/ml lysostaphin was added to the endothelial cells. After 20 min incubation, the wells were rinsed three times and the number of internalized bacteria was determined by lysing the host cells with cold distilled water followed by quantitative culture. Each strain was tested in duplicate in at least three different experiments.
Endothelial Cell Damage Assay
The extent of endothelial cell damage caused by the different strains of C. albicans was measured using our previously described 51Cr release assay . Briefly, host cells were loaded with 6 µCi/ml Na251CrO4 (MP Biomedicals) overnight. After removing the unincorporated 51Cr by rinsing, the cells were infected with yeast of the various C. albicans strains resuspended in RPMI 1640. The infected host cells were incubated for 6 h, after which the amount of 51Cr released into the medium and retained by the cells was determined by γ-counting. Wells containing host cells, but no organisms, were processed in parallel to determine the spontaneous release of 51Cr.
The amount of endothelial cell damage induced by S. aureus was also determined with a 51Cr release assay as previously described . Briefly, bacteria were added to the endothelial cells in M199 invasion medium for 3 h, after which 500 µl of fresh complete M-199 medium containing 10 µg/ml lysostaphin was added , . Damage was determined 24 h after infection at the indicated MOIs. Each strain and condition was tested in triplicate on at least three different occasions.
The optimal time for damage assay assessments for the two different organisms was determined after extensive pilot studies.
Detection of IL-8 in Conditioned Media
The effects of C. albicans and S. aureus on endothelial cell secretion of IL-8 were determined using the same inocula and incubation conditions as in the damage experiments, except that M-199 medium was used in both the C. albicans and S. aureus experiments. At the end of the defined incubation period, the conditioned medium above the endothelial cells was collected, centrifuged at 1,000 g to pellet the cells, and then frozen in aliquots at −80C for later analysis. The concentrations of IL-8 in conditioned media were determined by commercial enzyme-linked immunosorbent assays (Invitrogen) according to the manufacturer’s instructions. Each strain and condition was tested in duplicate in three independent experiments.
We thank David Viallareal and Quynh T. Phan for assistance with tissue culture. This work was part of the Master’s thesis of Mr. Steven Ellison at California State University-Dominguez Hills; Dominguez Hills, California.
Conceived and designed the experiments: KS SGF. Performed the experiments: KS NVS WAH SE MCK. Analyzed the data: KS NVS SE MCK SGF. Contributed reagents/materials/analysis tools: ASB YQX SGF. Wrote the paper: KS ASB YQX SGF.
- 1. Aird W (2008) Endothelium in health and disease. Pharmacol Rep 60(1) 139–43: 139–143.
- 2. Chorianopoulos E, Bea F, Katus H, Frey N (2009) The role of endothelial cell biology in endocarditis. Cell Tissue Res 335: 153–163.
- 3. Bezerra LML, Filler SG (2004) Interactions of Aspergillus fumigatus with endothelial cells: internalization, injury, and stimulation of tissue factor activity. Blood 103: 2143–2149.
- 4. Chiang LY, Sheppard DC, Gravelat FN, Patterson TF, Filler SG (2008) Aspergillus fumigatus stimulates leukocyte adhesion molecules and cytokine production by endothelial cells in vitro and during invasive pulmonary disease. Infect Immun 76: 3429–3438.
- 5. Filler SG, Pfunder AS, Spellberg BJ, Spellberg JP, Edwards JE Jr (1996) Candida albicans stimulates cytokine production and leukocyte adhesion molecule expression by endothelial cells. Infect Immun 64: 2609–2617.
- 6. Filler SG, Swerdloff JN, Hobbs C, Luckett PM (1995) Penetration and damage of endothelial cells by Candida albicans. Infect Immun 63: 976–983.
- 7. Kamai Y, Chiang LY, Lopes Bezerra LM, Doedt T, Lossinsky AS, et al. (2006) Interactions of Aspergillus fumigatus with vascular endothelial cells. Medical Mycology 44: 115–117.
- 8. Orozco AS, Zhou X, Filler SG (2000) Mechanisms of the proinflammatory response of endothelial cells to Candida albicans infection. Infect Immun 68: 1134–1141.
- 9. Park H, Liu Y, Solis N, Spotkov J, Hamaker J, et al. (2009) Transcriptional responses of Candida albicans to epithelial and endothelial cells. Eukaryot Cell 8: 1498–1510.
- 10. Phan Q, Filler SG (2009) Endothelial cell stimulation by Candida albicans. Methods Mol Biol 470: 313–326.
- 11. Phan QT, Belanger PH, Filler SG (2000) Role of hyphal formation in interactions of Candida albicans with endothelial cells. Infect Immun 68: 3485–3490.
- 12. Phan QT, Myers C, Fu Y, Sheppard DC, Yeaman MR, et al. (2007) Als3 is a Candida albicans invasin that binds to cadherins and induces endocytosis by host cells. PLoS Biol 2007 5: e64.
- 13. Sanchez AA, Johnston DA, Myers C, Edwards JE Jr, Mitchell AP, et al. (2004) Relationship between Candida albicans virulence during experimental hematogenously disseminated infection and endothelial cell damage in vitro. Infect Immun 72: 598–601.
- 14. Seidl K, Bayer AS, McKinnell JA, Ellison S, Filler SG, et al. (2011) In vitro endothelial cell damage is positively correlated with enhanced virulence and poor vancomycin responsiveness in experimental endocarditis due to methicillin resistant Staphylococcus aureus. Cell Microbiol 13: 1530–1541.
- 15. Sun JN, Solis NV, Phan QT, Bajwa JS, Kashleva H, et al. (2010) Host cell invasion and virulence mediated by Candida albicans Ssa1. PLoS Pathog 6: e1001181.
- 16. Scheglovitova O, Scanio V, Fais S, Papadia S, Abbate I, et al. (1995) Antibody to ICAM-1 mediates enhancement of HIV-1 infection of human endothelial cells. Arch Virol 140: 951–958.
- 17. Lidington EA, Moyes DL, McCormack AM, Rose ML (1999) A comparison of primary endothelial cells and endothelial cell lines for studies of immune interactions. Transplant Immunology 7: 239–246.
- 18. Oostingh GJ, Schlickum S, Friedl P, Schon MP (2007) Impaired induction of adhesion molecule expression in immortalized endothelial cells leads to functional defects in dynamic interactions with lymphocytes. J Invest Dermatol 127: 2253–2258.
- 19. Aird WC (2007) Phenotypic heterogeneity of the endothelium: II. Representative vascular beds. Circ Res 100: 174–190.
- 20. Aird WC (2007) Phenotypic heterogeneity of the endothelium: I. Structure, function, and mechanisms. Circ Res 100: 158–173.
- 21. Ades E, Candal F, Swerlick R, George V, Summers S, et al. (1992) HMEC-1: establishment of an immortalized human microvascular endothelial cell line. J Invest Dermatol 99: 683–690.
- 22. Coombes BK, Mahony JB (2001) cDNA array analysis of altered gene expression in human endothelial cells in response to Chlamydia pneumoniae infection. Infect Immun 69: 1420–1427.
- 23. Ferrero MC, Bregante J, Delpino MV, Barrionuevo P, Fossati CA, et al. (2011) Proinflammatory response of human endothelial cells to Brucella infection. Microbes Infect 13: 852–861.
- 24. Resto-Ruiz SI, Schmiederer M, Sweger D, Newton C, Klein TW, et al. (2002) Induction of a potential paracrine angiogenic loop between human THP-1 macrophages and human microvascular endothelial cells during Bartonella henselae infection. Infect Immun 70: 4564–4570.
- 25. Mehta PK, Karls RK, White EH, Ades EW, Quinn FD (2006) Entry and intracellular replication of Mycobacterium tuberculosis in cultured human microvascular endothelial cells. Microbial Pathogenesis 41: 119–124.
- 26. Cho N-H, Seong S-Y, Choi M-S, Kim I-S (2001) Expression of chemokine genes in human dermal microvascular endothelial cell lines infected with Orientia tsutsugamushi. Infect Immun 69: 1265–1272.
- 27. Rydkina E, Turpin LC, Sahni SK (2010) Rickettsia rickettsii infection of human macrovascular and microvascular endothelial cells reveals activation of both common and cell type-specific host response mechanisms. Infect Immun 78: 2599–2606.
- 28. Cleary IA, Reinhard SM, Miller CL, Murdoch C, Thornhill MH, et al. (2011 ) Candida albicans adhesin Als3p is dispensable for virulence in the mouse model of disseminated candidiasis. Microbiology 157: 1806–1815.
- 29. Grubb SEW, Murdoch C, Sudbery PE, Saville SPS, Lopez-Ribot JL, et al. (2009) Adhesion of Candida albicans to endothelial cells under physiological conditions of flow. Infect Immun 77: 3872–3878.
- 30. Esen M, Schreiner B, Jendrossek V, Lang F, Fassbender K, et al. (2001) Mechanisms of Staphylococcus aureus induced apoptosis of human endothelial cells. Apoptosis 6: 431–439.
- 31. Grundmeier M, Tuchscherr L, Brueck M, Viemann D, Roth J, et al. (2010) Staphylococcal strains vary greatly in their ability to induce an inflammatory response in endothelial cells. J Infect Dis 201: 871–880.
- 32. Haslinger-Löffler B, Kahl BC, Grundmeier M, Strangfeld K, Wagner B, et al. (2005) Multiple virulence factors are required for Staphylococcus aureus-induced apoptosis in endothelial cells. Cell Microbiol 7: 1087–1097.
- 33. Balwit J, van Langevelde P, Vann J, Proctor R (1994) Gentamicin-resistant menadione and hemin auxotrophic Staphylococcus aureus persist within cultured endothelial cells. J Infect Dis 170: 1033–1037.
- 34. Tuchscherr L, Heitmann V, Hussain M, Viemann D, Roth J, et al. (2010) Staphylococcus aureus small-colony variants are adapted phenotypes for intracellular persistence. J Infect Dis 202: 1031–1040.
- 35. Seidl K, Chen L, Bayer AS, Hady WA, Kreiswirth BN, et al. (2011) Relationship of agr expression and function with virulence and vancomycin treatment outcomes in experimental endocarditis due to methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 55: 5631–5639.
- 36. Krishnaswamy G, Kelley J, Yerra L, Smith J, Chi D (1999) Human endothelium as a source of multifunctional cytokines: molecular regulation and possible role in human disease. J Interferon Cytokine Res 19: 91–104.
- 37. Wilson D, Hube B (2010) Hgc1 mediates dynamic Candida albicans-endothelium adhesion events during circulation. Eukaryotic Cell 9: 278–287.
- 38. Phan QT, Fratti RA, Prasadarao NV, Edwards JE, Filler SG (2005) N-cadherin mediates endocytosis of Candida albicans by endothelial cells. J Biol Chem 280: 10455–10461.
- 39. Atalla H, Gyles C, Jacob CL, Moisan H, Malouin F, et al. (2008) Characterization of a Staphylococcus aureus small colony variant (SCV) associated with persistent bovine mastitis. Foodborne Pathog Dis 5: 785–799.
- 40. Mitchell G, Lamontagne C-A, Brouillette E, Grondin G, Talbot BG, et al. (2008) Staphylococcus aureus SigB activity promotes a strong fibronectin–bacterium interaction which may sustain host tissue colonization by small-colony variants isolated from cystic fibrosis patients. Mol Microbiol 70: 1540–1555.
- 41. Sinha B, Francois P, Que Y-A, Hussain M, Heilmann C, et al. (2000) Heterologously expressed Staphylococcus aureus fibronectin-binding proteins are sufficient for invasion of host cells. Infect Immun 68: 6871–6878.
- 42. Sinha B, François PP, Nüße O, Foti M, Hartford OM, et al. (1999) Fibronectin-binding protein acts as Staphylococcus aureus invasin via fibronectin bridging to integrin α5β1. Cell Microbiol 1: 101–117.
- 43. Pöhlmann-Dietze P, Ulrich M, Kiser KB, Döring G, Lee JC, et al. (2000) Adherence of Staphylococcus aureus to endothelial cells: influence of capsular polysaccharide, global regulator agr, and bacterial growth phase. Infect Immun 68: 4865–4871.
- 44. Shenkman B, Varon D, Tamarin I, Dardik R, Peisachov M, et al. (2002) Role of agr (RNAIII) in Staphylococcus aureus adherence to fibrinogen, fibronectin, platelets and endothelial cells under static and flow conditions. J Med Microbiol 51.
- 45. Strindhall J, Lindgren PE, Löfgren S, Kihlström E (2005) Clinical isolates of Staphylococcus aureus vary in ability to stimulate cytokine expression in human endothelial cells. Scand J Immunol 61: 57–62.
- 46. Tajima A, Iwase T, Shinji H, Seki K, Mizunoe Y (2009) Inhibition of endothelial interleukin-8 production and neutrophil transmigration by Staphylococcus aureus beta-hemolysin. Infect Immun 77: 327–334.
- 47. Yao L, Lowy FD, Berman JW (1996) Interleukin-8 gene expression in Staphylococcus aureus-infected endothelial cells. Infect Immun 64: 3407–3409.
- 48. Nanobashvili J, Jozkowicz A, Neumayer C, Fügl A, Sporn E, et al. (2003) Comparison of angiogenic potential of human microvascular endothelial cells and human umbilical vein endothelial cells. Eur Surg 35: 214–218.
- 49. Jaffe EA, Nachman RL, Becker CG, Minick CR (1973) Culture of human endothelial cells derived from umbilical veins: Identification by morphologic and immunologic criteria. J Clin Invest 52: 2745–2756.
- 50. Pang YY, Schwartz J, Thoendel M, Ackermann LW, Horswill AR, et al. (2010) agr-dependent interactions of Staphylococcus aureus USA300 with human polymorphonuclear neutrophils. J Innate Immun 2 546–559.
- 51. Cheung AL, Bayles KW (2007) Tissue culture assays used to analyze invasion by Staphylococcus aureus. Curr Protoc Microbiol. 9C.4.1 p.
- 52. Suzuki T, Swoboda JG, Campbell J, Walker S, Gilmore MS (2011) In vitro antimicrobial activity of wall teichoic acid biosynthesis inhibitors against Staphylococcus aureus isolates. Antimicrob Agents Chemother 55: 767–774.
- 53. Vann JM, Proctor RA (1987) Ingestion of Staphylococcus aureus by bovine endothelial cells results in time- and inoculum-dependent damage to endothelial cell monolayers. Infect Immun 55: 2155–2163.
- 54. Davis D, Wilson RB, Mitchell AP (2000) RIM101-dependent and -independent pathways govern pH responses in Candida albicans. Mol Cell Biol 20: 971–978.
- 55. Fradin C, De Groot P, MacCallum D, Schaller M, Klis F, et al. (2005) Granulocytes govern the transcriptional response, morphology and proliferation of Candida albicans in human blood. Mol Microbiol 56: 397–415.